Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$110,392,405
-$12,718,372 QoQ
Shares Held
1,172,890
-5.9% QoQ
Ownership
0.587%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89.07024529154481.ToString("F0")%
Shared 0.ToString("F0")%
None 10.929754708455183.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. INCY ranks #74 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,392,405 | 1,172,890 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $123,110,777 | 1,246,439 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $107,883,067 | 1,272,056 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $78,756,014 | 1,156,476 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $90,631,117 | 1,496,798 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $73,444,200 | 1,063,330 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $87,282,997 | 1,320,469 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $108,352,670 | 1,787,408 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $92,513,695 | 1,623,902 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $83,518,170 | 1,330,119 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $89,933,502 | 1,556,751 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $70,132,716 | 1,126,630 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $86,094,743 | 1,191,293 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $84,232,305 | 1,048,709 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $75,077,088 | 1,126,607 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $85,417,397 | 1,124,357 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $52,351,439 | 659,172 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $26,315,513 | 358,522 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,824,688 | 375,468 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $67,449,880 | 801,734 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $64,132,269 | 789,126 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $42,603,150 | 489,804 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $41,011,538 | 457,004 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $41,106,929 | 395,373 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $16,035,464 | 218,974 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||